STAT Plus: Pharmalittle: Judge blocks Trump plan to run drug prices in TV ads; former Insys execs cooperate with the feds
Hello, everyone, and how are you today? We are doing just fine, thank you, since a cool breeze and sunny skies are enveloping the Pharmalot campus. One short person has left for work and the other is sleeping in, as is the official mascot. This leaves us to focus on matters at hand, which start with brewing cups of stimulation (butter pecan, for those keeping track) and foraging for items of interest. Speaking of which, here is a new batch. Hope your day goes well and do keep us in mind when something saucy occurs …
A federal judge blocked a Trump administration regulation that requires drug makers to include list prices in ads, STAT writes. The decision, which came just hours before the rule was set to take effect, came after three drug makers sued the administration, arguing the Department of Health and Human Services did not have the authority to require the disclosures and requiring them violated First Amendment rights. While agreeing that HHS overstepped its authority in requiring such disclosures, the judge did not rule on the First Amendment concerns.
Continue to STAT Plus to read the full story…
